Join
Live feed
·
INSIDERFilingvia Quantisnow
Marker Therapeutics Inc. logo

SEC Form 4: Eansor Norman David was granted 12,658 units of Common Stock, increasing direct ownership by 52% to 36,940 units

ByQuantisnow·Wall Street's wire, on your screen.
MRKR· Marker Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MRKR (Marker Therapeutics Inc.) and more on Quantisnow.